Corrigendum to “Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke” [Free Radic. Biol. Med. 104 (2017) 333–345] (S089158491730059X) (10.1016/j.freeradbiomed.2017.01.034));Combined NADPH and the NOX inhibitor apocynin provides greater anti-inflammatory and neuroprotective effects in a mouse model of stroke

Free Radical Biology and Medicine

Volumn 104, Issue , 2017, Pages 333-345

  Qin, Yuan Yuan ^a,c   Li, Mei ^b   Feng, Xing ^b   Wang, Jian ^b   Cao, Lijuan ^a   Shen, Xi Kui ^c   Chen, Jieyu ^a   Sun, Meiling ^a   Sheng, Rui ^a   Han, Feng ^d   Qin, Zheng Hong ^a  

^a SOOCHOW UNIVERSITY   (China)

^b CHILDREN S HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^c Jiangsu Suzhou Hospital of Tradition Chinese Medicine   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

Apocynin; Inflamasome; NADPH; NOX; Stroke

Indexed keywords

APOCYNIN; CRYOPYRIN; I KAPPA B KINASE ALPHA; INDUCIBLE NITRIC OXIDE SYNTHASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; TRANSCRIPTION FACTOR RELA; ACETOPHENONE DERIVATIVE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NEUROPROTECTIVE AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NOS2 PROTEIN, MOUSE; PTGS2 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN CORTEX; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN WATER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; MOUSE MODEL; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REPERFUSION INJURY; SURVIVAL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CEREBROVASCULAR ACCIDENT; DISEASE MODEL; GENETICS; HUMAN; INFLAMMATION; METABOLISM; PATHOLOGY;

ACETOPHENONES; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRAIN ISCHEMIA; CYCLOOXYGENASE 2; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MICE; NADP; NADPH OXIDASES; NEUROPROTECTIVE AGENTS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; REPERFUSION INJURY; STROKE;

EID: 85012254007     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2017.12.023     Document Type: Erratum

References (41)

1. [1] Donnan, G.A., Fisher, M., Macleod, M., Davis, S.M., Stroke. Lancet 371 (2008), 1612–1623.
2. [2] Slemmer, J.E., Shacka, J.J., Sweeney, M.I., Weber, J.T., Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr. Med. Chem. 15 (2008), 404–414.
3. [3] Kleinschnitz, C., Grund, H., Wingler, K., Armitage, M.E., Jones, E., Mittal, M., Barit, D., Schwarz, T., Geis, C., Kraft, P., Barthel, K., Schuhmann, M.K., Herrmann, A.M., Meuth, S.G., Stoll, G., Meurer, S., Schrewe, A., Becker, L., Gailus-Durner, V., Fuchs, H., Klopstock, T., de Angelis, M.H., Jandeleit-Dahm, K., Shah, A.M., Weissmann, N., Schmidt, H.H., Post-stroke inhibition of induced nadph oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol., 8, 2010.
4. [4] Sugawara, T., Chan, P.H., Reactive oxygen radicals and pathogenesis of neuronal death after cerebral ischemia. Antioxid. Redox Signal. 5 (2003), 597–607.
5. [5] Ying, W., Nad+/nadh and nadp+/nadph in cellular functions and cell death: regulation and biological consequences. Antioxid. Redox Signal 10 (2008), 179–206.
6. [6] Li, M., Zhou, Z.P., Sun, M., Cao, L., Chen, J., Qin, Y.Y., Gu, J.H., Han, F., Sheng, R., Wu, J.C., Ding, Y., Qin, Z.H., Reduced nicotinamide adenine dinucleotide phosphate, a pentose phosphate pathway product, might be a novel drug candidate for ischemic stroke. Stroke 47 (2016), 187–195.
7. [7] Chen, H., Song, Y.S., Chan, P.H., Inhibition of nadph oxidase is neuroprotective after ischemia-reperfusion. J. Cereb. Blood Flow. Metab. 29 (2009), 1262–1272.
8. [8] Davis, B.K., Wen, H., Ting, J.P., The inflammasome nlrs in immunity, inflammation, and associated diseases. Annu. Rev. Immunol. 29 (2011), 707–735.
9. [9] Schroder, K., Tschopp, J., The inflammasomes. Cell 140 (2010), 821–832.
10. [10] Stutz, A., Golenbock, D.T., Latz, E., Inflammasomes: too big to miss. J. Clin. Invest. 119 (2009), 3502–3511.
11. [11] Ma, Q., Chen, S., Hu, Q., Feng, H., Zhang, J.H., Tang, J., Nlrp3 inflammasome contributes to inflammation after intracerebral hemorrhage. Ann. Neurol. 75 (2014), 209–219.
12. [12] Fann, D.Y., Lee, S.Y., Manzanero, S., Tang, S.C., Gelderblom, M., Chunduri, P., Bernreuther, C., Glatzel, M., Cheng, Y.L., Thundyil, J., Widiapradja, A., Lok, K.Z., Foo, S.L., Wang, Y.C., Li, Y.I., Drummond, G.R., Basta, M., Magnus, T., Jo, D.G., Mattson, M.P., Sobey, C.G., Arumugam, T.V., Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis., 4, 2013, e790.
13. [13] Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., Golenbock, D.T., The nalp3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 (2008), 857–865.
14. [14] Abulafia, D.P., de Rivero Vaccari, J.P., Lozano, J.D., Lotocki, G., Keane, R.W., Dietrich, W.D., Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. J. Cereb. Blood Flow. Metab. 29 (2009), 534–544.
15. [15] Yang, F., Wang, Z., Wei, X., Han, H., Meng, X., Zhang, Y., Shi, W., Li, F., Xin, T., Pang, Q., Yi, F., Nlrp3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J. Cereb. Blood Flow. Metab. 34 (2014), 660–667.
16. [16] Simard, J.C., Cesaro, A., Chapeton-Montes, J., Tardif, M., Antoine, F., Girard, D., Tessier, P.A., S100a8 and s100a9 induce cytokine expression and regulate the nlrp3 inflammasome via ros-dependent activation of nf-kappab(1.). PLoS One, 8, 2013, e72138.
17. [17] Abais, J.M., Zhang, C., Xia, M., Liu, Q., Gehr, T.W., Boini, K.M., Li, P.L., Nadph oxidase-mediated triggering of inflammasome activation in mouse podocytes and glomeruli during hyperhomocysteinemia. Antioxid. Redox Signal. 18 (2013), 1537–1548.
18. [18] Lambeth, J.D., Nox enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4 (2004), 181–189.
19. [19] Van den Worm E, Beukelman, C.J., Van den Berg, A.J., Kroes, B.H., Labadie, R.P., Van Dijk, H., Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur. J. Pharmacol. 433 (2001), 225–230.
20. [20] Liou, K.T., Shen, Y.C., Chen, C.F., Tsao, C.M., Tsai, S.K., Honokiol protects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res. 992 (2003), 159–166.
21. [21] Clark, W.M., Lessov, N.S., Dixon, M.P., Eckenstein, F., Monofilament intraluminal middle cerebral artery occlusion in the mouse. Neurol. Res. 19 (1997), 641–648.
22. [22] Li, M., Sun, M., Cao, L., Gu, J.H., Ge, J., Chen, J., Han, R., Qin, Y.Y., Zhou, Z.P., Ding, Y., Qin, Z.H., A tigar-regulated metabolic pathway is critical for protection of brain ischemia. J. Neurosci. 34 (2014), 7458–7471.
23. [23] Swanson, R.A., Morton, M.T., Tsao-Wu, G., Savalos, R.A., Davidson, C., Sharp, F.R., A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow. Metab. 10 (1990), 290–293.
24. [24] Mdzinarishvili, A., Kiewert, C., Kumar, V., Hillert, M., Klein, J., Bilobalide prevents ischemia-induced edema formation in vitro and in vivo. Neuroscience 144 (2007), 217–222.
25. [25] Hatashita, S., Hoff, J.T., Salamat, S.M., Ischemic brain edema and the osmotic gradient between blood and brain. J. Cereb. Blood Flow. Metab. 8 (1988), 552–559.
26. [26] Chen, J., Li, Y., Wang, L., Zhang, Z., Lu, D., Lu, M., Chopp, M., Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001), 1005–1011.
27. [27] Muller, H.D., Hanumanthiah, K.M., Diederich, K., Schwab, S., Schabitz, W.R., Sommer, C., Brain-derived neurotrophic factor but not forced arm use improves long-term outcome after photothrombotic stroke and transiently upregulates binding densities of excitatory glutamate receptors in the rat brain. Stroke 39 (2008), 1012–1021.
28. [28] Nakayama, M., Uchimura, K., Zhu, R.L., Nagayama, T., Rose, M.E., Stetler, R.A., Isakson, P.C., Chen, J., Graham, S.H., Cyclooxygenase-2 inhibition prevents delayed death of CA1 hippocampal neurons following global ischemia. Proc. Natl. Acad. Sci. USA. 95 (1998), 10954–10959.
29. [29] Gu, J.H., Ge, J.B., Li, M., Wu, F., Zhang, W., Qin, Z.H., Inhibition of nf-kappab activation is associated with anti-inflammatory and anti-apoptotic effects of ginkgolide b in a mouse model of cerebral ischemia/reperfusion injury. Eur. J. Pharm. Sci. 47 (2012), 652–660.
30. [30] Bedard, K., Krause, K.H., The nox family of ros-generating nadph oxidases: physiology and pathophysiology. Physiol. Rev. 87 (2007), 245–313.
31. [31] Wang, Q., Tompkins, K.D., Simonyi, A., Korthuis, R.J., Sun, A.Y., Sun, G.Y., Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res. 1090 (2006), 182–189.
32. [32] Lewis, C.A., Parker, S.J., Fiske, B.P., McCloskey, D., Gui, D.Y., Green, C.R., Vokes, N.I., Feist, A.M., Vander Heiden, M.G., Metallo, C.M., Tracing compartmentalized nadph metabolism in the cytosol and mitochondria of mammalian cells. Mol. Cell. 55 (2014), 253–263.
33. [33] Pollak, N., Niere, M., Ziegler, M., Nad kinase levels control the nadph concentration in human cells. J. Biol. Chem. 282 (2007), 33562–33571.
34. [34] Pittelli, M., Felici, R., Pitozzi, V., Giovannelli, L., Bigagli, E., Cialdai, F., Romano, G., Moroni, F., Chiarugi, A., Pharmacological effects of exogenous nad on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol. Pharmacol. 80 (2011), 1136–1146.
35. [35] Nikiforov, A., Dolle, C., Niere, M., Ziegler, M., Pathways and subcellular compartmentation of nad biosynthesis in human cells: from entry of extracellular precursors to mitochondrial nad generation. J. Biol. Chem. 286 (2011), 21767–21778.
36. [36] Canto, C., Menzies, K.J., Auwerx, J., Nad(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus. Cell Metab. 22 (2015), 31–53.
37. [37] Baeuerle, P.A., Henkel, T., Function and activation of nf-kappa b in the immune system. Annu. Rev. Immunol. 12 (1994), 141–179.
38. [38] Zhang, H.L., Gu, Z.L., Savitz, S.I., Han, F., Fukunaga, K., Qin, Z.H., Neuroprotective effects of prostaglandin a(1) in rat models of permanent focal cerebral ischemia are associated with nuclear factor-kappaB inhibition and peroxisome proliferator-activated receptor-gamma up-regulation. J. Neurosci. Res. 86 (2008), 1132–1141.
39. [39] Li, H.L., Huang, Y., Zhang, C.N., Liu, G., Wei, Y.S., Wang, A.B., Liu, Y.Q., Hui, R.T., Wei, C., Williams, G.M., Liu, D.P., Liang, C.C., Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic. Biol. Med. 40 (2006), 1756–1775.
40. [40] Abais, J.M., Xia, M., Zhang, Y., Boini, K.M., Li, P.L., Redox regulation of nlrp3 inflammasomes: Ros as trigger or effector?. Antioxid. Redox Signal. 22 (2015), 1111–1129.
41. [41] Bauernfeind, F.G., Horvath, G., Stutz, A., Alnemri, E.S., MacDonald, K., Speert, D., Fernandes-Alnemri, T., Wu, J., Monks, B.G., Fitzgerald, K.A., Hornung, V., Latz, E., Cutting edge: nf-kappab activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J. Immunol. 183 (2009), 787–791.